| 10 | 20231127 | Additional Listing(무상증자) | KOSDAQ STOCK MKT. |
| 9 | 20231120 | Additional Listing(유상증자(구주주배정)) | KOSDAQ STOCK MKT. |
| 8 | 20231109 | Ex-Rights(무상증자) | KOSDAQ STOCK MKT. |
| 7 | 20231109 | Results of issuance(Voluntary Disclosure)(주주배정 후 실권주 일반공모 유상증자) | |
| 6 | 20231108 | Results of Subscription (Voluntary Disclosure) | |
| 5 | 20231103 | Results of Subscription (Voluntary Disclosure) | |
| 4 | 20231030 | Designation of overheated short-selling issues (applied by a restriction on short-selling) | KOSDAQ STOCK MKT. |
| 3 | 20231030 | [Revised]Decision on Paid-in Capital Increase/Capital Increase without Consideration(주주배정후 실권주 일반공모) | |
| 2 | 20231023 | Material Management Information related to Judgment of Investment(유선종양에 이환된 개에서 수술 후 적용하는 항암병용치료제(Vaxleukin-15 inj.) 품목허가 신청) | |
| 1 | 20231012 | Subscription Right Newly listed(박셀바이오 20R) | KOSDAQ STOCK MKT. |
